A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined with Capecitabine in the Treatment of Active Brain Metastasis of TNBC

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 19, 2024

Primary Completion Date

June 1, 2026

Study Completion Date

August 1, 2026

Conditions

Metastatic Breast Cancer

Interventions

DRUG

Utidelone and capecitabine

Utidelone: intravenous capecitabine: oral

Trial Locations (1)

RECRUITING

Henan Breast Cancer Center, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou

All Listed Sponsors

lead

Henan Cancer Hospital

OTHER_GOV